Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 66

Connective Tissue Disorder

Emergencies
DR.Rajesh Gubba
• All the Connective tissue disorders are multi system disorders.


Rheumatoid Arthritis Ankylosing Behcets syndrome Reiters syndrome
Spondylitis

Cause of Death

Pathognomic
manifestation

C/F emergency

Other features

IOC & HLA association

Treatment

Treatment of
Emergency
• Deformities seen with hand involvement
• Swan Neck deformity  Hyperextension of PIP joint.
• Button hole deformity  Hyperextension of DIP joint.

4
Rheumatoid Arthritis Ankylosing Behcets syndrome Reiters syndrome
Spondylitis

Cause of Death Ischemic heart disease # Rigid osteoporotic Pulmonary artery Cardiac Conduction
spine vasculitis – PA defects
aneurysms
Pathognomic Small Joint Spine & SI joint Oral ulcers Triad – A,U,C
manifestation involvement

C/F emergency Chest pain Severe pain – Spine Dyspnea Giddiness & Syncopal
FND attack

Other features

IOC & HLA association Anti CCP Sr.Matrix metallo HLA b5,51 HLA B27
HLA DR3,4 proteinase 3

Treatment NSAIDS,Steroids NSAIDS Colchicine & Analgesics,


Methotrexate TNF alpha(-)/IL 17 A(-) Steroids(Topical) Tetracyclines,Steroids

Treatment of
Emergency
Rheumatoid Arthritis Ankylosing Behcets syndrome Reiters syndrome
Spondylitis

Cause of Death

Pathognomic
manifestation

C/F emergency

Other features

IOC & HLA association

Treatment

Treatment of
Emergency
Rheumatoid Arthritis Ankylosing Behcets syndrome Reiters syndrome
Spondylitis

Cause of Death Ischemic heart disease # Rigid osteoporotic Pulmonary artery Cardiac Conduction
spine vasculitis – PA defects
aneurysms
Pathognomic Small Joint Spine & SI joint Oral ulcers Triad – A,U,C
manifestation involvement

C/F emergency Chest pain Severe pain – Spine Dyspnea Giddiness & Syncopal
FND attack

Other features

IOC & HLA association Anti CCP Sr.Matrix metallo HLA b5,51 HLA B27
HLA DR3,4 proteinase 3

Treatment NSAIDS,Steroids NSAIDS Colchicine & Analgesics,


Methotrexate TNF alpha(-)/IL 17 A(-) Steroids(Topical) Tetracyclines,Steroids

Treatment of
Emergency
Rheumatoid Arthritis Ankylosing Behcets syndrome Reiters syndrome
Spondylitis

Cause of Death

Pathognomic
manifestation

C/F emergency

Other features

IOC & HLA association

Treatment

Treatment of
Emergency
Rheumatoid Arthritis Ankylosing Behcets syndrome Reiters syndrome
Spondylitis

Cause of Death Ischemic heart disease # Rigid osteoporotic Pulmonary artery Cardiac Conduction
spine vasculitis – PA defects
aneurysms
Pathognomic Small Joint Spine & SI joint Oral ulcers Triad – A,U,C
manifestation involvement

C/F emergency Chest pain Severe pain – Spine Dyspnea Giddiness & Syncopal
FND attack

Other features

IOC & HLA association Anti CCP Sr.Matrix metallo HLA b5,51 HLA B27
HLA DR3,4 proteinase 3

Treatment NSAIDS,Steroids NSAIDS Colchicine & Analgesics,


Methotrexate TNF alpha(-)/IL 17 A(-) Steroids(Topical) Tetracyclines,Steroids

Treatment of
Emergency
12
• Eye involvement may be one of the most devastating complications of Behcet
disease.

• Posterior uveitis, in essence a retinal venulitis, may lead to the insidious


destruction of large areas of the retina before the patient becomes aware of visual
problems.

• Anterior uveitis, associated with the triad of photophobia, blurred vision, and a red
eye, is intensely symptomatic.

13
What is the complication of Anterior
Uveitis?
• This complication may lead to a hypopyon, the accumulation of pus in
the anterior chamber.

• If not treated properly with mydriatic agents to dilate the pupil and
corticosteroid eyedrops to diminish inflammation, the anterior uveitis
may lead to synechial formation between the iris and lens, resulting in
permanent pupillary distortion.
15
Rheumatoid Arthritis Ankylosing Behcets syndrome Reiters syndrome
Spondylitis

Cause of Death

Pathognomic
manifestation

C/F emergency

Other features

IOC & HLA association

Treatment

Treatment of
Emergency
Rheumatoid Arthritis Ankylosing Behcets syndrome Reiters syndrome
Spondylitis

Cause of Death Ischemic heart disease # Rigid osteoporotic Pulmonary artery Cardiac Conduction
spine vasculitis – PA defects
aneurysms
Pathognomic Small Joint Spine & SI joint Oral ulcers Triad – A,U,C
manifestation involvement

C/F emergency Chest pain Severe pain – Spine Dyspnea Giddiness & Syncopal
FND attack

Other features

IOC & HLA association Anti CCP Sr.Matrix metallo HLA b5,51 HLA B27
HLA DR3,4 proteinase 3

Treatment NSAIDS,Steroids NSAIDS Colchicine & Analgesics,


Methotrexate TNF alpha(-)/IL 17 A(-) Steroids(Topical) Tetracyclines,Steroids

Treatment of
Emergency
SLE Sjogrens syndrome Gouty Arthrits Marfans syndrome

Cause of Death

Pathognomic
manifestation

C/F emergency

Other features

IOC & HLA association

Treatment

Treatment of
Emergency
SLE Sjogrens syndrome Gouty Arthrits Marfans syndrome

Cause of Death Cardiac involvement > CAD (Thrombo Cardiovascular death Pneumothorax
Renal failure embolism) Aortic dissection

Pathognomic MC- Next slide Dry eyes & Dry mouth 1st MTP joint Flexible joints
manifestation involvement

C/F emergency CHF Chest pain Chest pain Sudden onset dyspnea
Chest pain

Other features Extraglandular Ghents criteria


features

IOC & HLA association HLA-DRB1 Synovial fluid analysis FBN 1 gene mutation

Treatment Steroids NSAIDS, Steroids, Col Labetolol


Allopurinol,Febuxostat Aortic root stenting

Treatment of Diuretics TLT


Emergency
SLE
• MC presentation of SLE is fatigue, malaise, fever and arthralgia:
95%.

• This is followed by hematological and cutaneous manifestations.

20
Clinical Features of SLE
• Malar rash Butterfly rash (MC acute SLE rash)

• Fixed erythema, flat or raised, over the malar eminences and sun
exposed parts.

21
• Discoid rash
• Erythematous circular raised patches with adherent keratotic scaling
and follicular plugging; atrophic scarring may occur.

22
• Photosensitivity (Ro/SS-A antibody)
• Exposure to sunlight leads to rash/ sun burn
• Treatment: Hydroxychloroquine and sunscreen lotion

23
• Oral ulcers
• They are superficial small ulcers which are painless
and occur on hard palate, buccal cavity and
vermiform border.

24
• Synovitis
• This involves hands, wrists, knee j oints and is non-
erosive

Non-erosive arthritis is seen in cases of:


1. Rheumatic fever

2. Inflammatory bowel disease

3 . SLE

25
• Musculoskeletal manifestation in SLE :-

• Polyarthralgias and polyarthritis eventually occur in 90% of SLE patients.

• The arthritis initially involve the small joints in hands, knees and wrists.

• Joint deformities develop in only 10%.

• Erosions on joints X-rays are rare, their presence suggest a non lupus
inflammatory arthropathy such as rheumatoid arthritis

26
• Cardiovascular Features
• Myocarditis and pericarditis.

• Endocarditis (Libman-Sacks endocarditis).

• A higher risk of coronary artery disease compared to general population due to


increased risk of atherosclerosis and vasculitis.

27
• Cardiac involvement:
• MC involvement is pericarditis.

• Libman Sacks endocarditis is the characteristic feature of


cardiac SLE.

• Chest pain at rest due to irritation of phrenic nerve

• Upon auscultation: Pericardial friction rub

• IOC: ECG, ST elevation; Concave upwards in all leads except aVR.

• Rx of Libman Sacks endocarditis: Valvuloplasty.


28
• Lung involvement in SLE :-

• Pleuritis and pleural effusions (most common pulmonary manifestations


affecting almost 50% of patients).

• MC lung involvement in SLE: Pleuritis.

• Alveolar injury can also occur in the form of edema and hemorrhage.

• In some cases there is chronic interstitial fibrosis.

• Rare involvement is Shrinking lung syndrome and intraalveolar


hemorrhage 29
• Characterized by unexplained dyspnea, a restrictive
pattern on pulmonary function tests, and an elevated
hemidiaphragm.

• The chest radiograph reveals elevated diaphragms,


and pulmonary function tests shows reduced lung
volumes.

• This condition has been describe as "shrinking lung"


and is thought to be caused by diaphragmatic
myopathy

30
31
• Kidney involvement: Lupus nephritis

• Present with hematuria (cola-colored urine)

32
• Classification of Lupus Nephritis (International Society
ofNephrology and Renal Pathology Society)
• Class 1: Minimal Mesangial Lupus Nephritis

• Class II : Mesangial Proliferative Lupus Nephritis

• Class Ill : Focal Lupus Nephritis

• Class IV: Diffuse Lupus Nephritis

• Class V: Membranous Lupus Nephritis

• Class VI: Advanced Sclerotic Lupus Nephritis

33
• Investigations:
• a. Urine m/e- >3 RBC/HPF and presence of RBC casts

• b. Urine protein concentration: 0.5 - l g/24 hours

34
• d. IOC: For lupus nephritis kidney biopsy.

• Upon HPE, wire loop lesion is characteristic finding.

• Most severe stage of lupus nephritis: Stage IV (diffuse


lupus nephritis)

• Treatment: Hemodialysis if GFR < 30 mL

• Transplantation if GFR < 1 5 mL (ESRD).


35
• Psychosis/ Lupus Cerebritis:-
• Lupus antibody can cross (blood brain barrier) and can
cause cerebral edema and seizures.

• MC CNS manifestation: Cognition defect (antibody = Anti-


neuronal Ab)

• MC psychiatric manifestation: Psychosis [antibody=


AntiRNP ( ribonucleoprotein)Ab]

• Treatment: Haloperidol

• Spinal cord involvement in form of myelopathy 36


37
• Hematological manifestation:
• Autoimmune hemolytic anemia because antibodies
destroys own RBC.

• These are warm antibodies: IgG  active at 37°C

• On peripheral smear: Spherocytes seen

• IOC: Direct Coomb's test

• Treatment: Steroids

38
• Lymphopenia and thrombocytopenia is also seen.
• Immunological manifestations in SLE
• ANA > upper reference limits
• Anti-ds DNA
• Anti-Sm
• Antiphospholipid antibody
• Low serum complement
• Positive direct Coombs test

39
SLE Sjogrens syndrome Gouty Arthrits Marfans syndrome

Cause of Death

Pathognomic
manifestation

C/F emergency

Other features

IOC & HLA association

Treatment

Treatment of
Emergency
SLE Sjogrens syndrome Gouty Arthrits Marfans syndrome

Cause of Death Cardiac involvement > CAD (Thrombo Cardiovascular death Pneumothorax
Renal failure embolism) Aortic dissection

Pathognomic MC- Next slide Dry eyes & Dry mouth 1st MTP joint Flexible joints
manifestation involvement

C/F emergency CHF Chest pain Chest pain Sudden onset dyspnea
Chest pain

Other features Extraglandular Ghents criteria


features

IOC & HLA association HLA-DRB1 Synovial fluid analysis FBN 1 gene mutation

Treatment Steroids NSAIDS, Steroids, Col Labetolol


Allopurinol,Febuxostat Aortic root stenting

Treatment of Diuretics TLT


Emergency
42
• Extraglandular manifestation of sjogren's syndrome
• Arthralgias / arthritis - MC extraglandular manifestation in
primary Sjogren is arthralgia/arthritis.
• Least common involvement is myositis.

• Raynaud's phenomenon

• Lymphadenopathy

• Lung involvement

• Vasculitis

• Kidney involvement 43
• Liver involvement

• Lymphoma

• Splenomegaly

• Peripheral neuropathy

• Myositis
44
SLE Sjogrens syndrome Gouty Arthrits Marfans syndrome

Cause of Death

Pathognomic
manifestation

C/F emergency

Other features

IOC & HLA association

Treatment

Treatment of
Emergency
SLE Sjogrens syndrome Gouty Arthrits Marfans syndrome

Cause of Death Cardiac involvement > CAD (Thrombo Cardiovascular death Pneumothorax
Renal failure embolism) Aortic dissection

Pathognomic MC- Next slide Dry eyes & Dry mouth 1st MTP joint Flexible joints
manifestation involvement

C/F emergency CHF Chest pain Chest pain Sudden onset dyspnea
Chest pain

Other features Extraglandular Ghents criteria


features

IOC & HLA association HLA-DRB1 Synovial fluid analysis FBN 1 gene mutation

Treatment Steroids NSAIDS, Steroids, Col Labetolol


Allopurinol,Febuxostat Aortic root stenting

Treatment of Diuretics TLT


Emergency
SLE Sjogrens syndrome Gouty Arthrits Marfans syndrome

Cause of Death

Pathognomic
manifestation

C/F emergency

Other features

IOC & HLA association

Treatment

Treatment of
Emergency
SLE Sjogrens syndrome Gouty Arthrits Marfans syndrome

Cause of Death Cardiac involvement > CAD (Thrombo Cardiovascular death Pneumothorax
Renal failure embolism) < Aortic dissection

Pathognomic MC- Next slide Dry eyes & Dry mouth 1st MTP joint Flexible joints
manifestation involvement

C/F emergency CHF Chest pain Chest pain Sudden onset dyspnea
Chest pain

Other features Extraglandular Ghents criteria


features

IOC & HLA association HLA-DRB1 Synovial fluid analysis FBN 1 gene mutation

Treatment Steroids NSAIDS, Steroids, Col Labetolol


Allopurinol,Febuxostat Aortic root stenting

Treatment of Diuretics TLT


Emergency
Scleroderma APLA syndrome Giant cell Arteritis Takayasu arteritis

Cause of Death

Pathognomic
manifestation

C/F emergency

Other features

IOC

Treatment

Treatment of
Emergency
Scleroderma APLA syndrome Giant cell Arteritis Takayasu arteritis

Cause of Death P.HTN CAD Cardiovascular CAD

Pathognomic Skin involvement Recurrent abortions Head ache Pulseless disease


manifestation Raynauds

C/F emergency Dyspnea Arterial /Venous MI/CHF/Aortic MI


occlusion dissection

Other features EYE Other vessels


PMR

IOC Anti Centromere Anticardiolipin Biopsy MRI Aorta


Anti Topoisomerase Anti b2 Glycoprotein 1
Lupus Anticoagulant
Treatment Steroids Anticoagulants & Steroids Steroids
Aspirin

Treatment of PAH lowering drugs TLT


Emergency
55
56
57
58
Scleroderma APLA syndrome Giant cell Arteritis Takayasu arteritis

Cause of Death

Pathognomic
manifestation

C/F emergency

Other features

IOC

Treatment

Treatment of
Emergency
Scleroderma APLA syndrome Giant cell Arteritis Takayasu arteritis

Cause of Death P.HTN CAD Cardiovascular CAD

Pathognomic Skin involvement Recurrent abortions Head ache Pulseless disease


manifestation Raynauds

C/F emergency Dyspnea Arterial /Venous MI/CHF/Aortic MI


occlusion dissection

Other features EYE Other vessels


PMR

IOC Anti Centromere Anticardiolipin Biopsy MRI Aorta


Anti Topoisomerase Anti b2 Glycoprotein 1
Lupus Anticoagulant
Treatment Steroids Anticoagulants & Steroids Steroids
Aspirin

Treatment of PAH lowering drugs TLT


Emergency
Scleroderma APLA syndrome Giant cell Arteritis Takayasu arteritis

Cause of Death

Pathognomic
manifestation

C/F emergency

Other features

IOC

Treatment

Treatment of
Emergency
Scleroderma APLA syndrome Giant cell Arteritis Takayasu arteritis

Cause of Death P.HTN CAD Cardiovascular CAD

Pathognomic Skin involvement Recurrent abortions Head ache Pulseless disease


manifestation Raynauds

C/F emergency Dyspnea Arterial /Venous MI/CHF/Aortic MI


occlusion dissection

Other features EYE Other vessels


PMR

IOC Anti Centromere Anticardiolipin Biopsy MRI Aorta


Anti Topoisomerase Anti b2 Glycoprotein 1
Lupus Anticoagulant
Treatment Steroids Anticoagulants & Steroids Steroids
Aspirin

Treatment of PAH lowering drugs TLT


Emergency
63
Scleroderma APLA syndrome Giant cell Arteritis Takayasu arteritis

Cause of Death

Pathognomic
manifestation

C/F emergency

Other features

IOC

Treatment

Treatment of
Emergency
Scleroderma APLA syndrome Giant cell Arteritis Takayasu arteritis

Cause of Death P.HTN CAD Cardiovascular CAD

Pathognomic Skin involvement Recurrent abortions Head ache Pulseless disease


manifestation Raynauds

C/F emergency Dyspnea Arterial /Venous MI/CHF/Aortic MI


occlusion dissection

Other features EYE Other vessels


PMR

IOC Anti Centromere Anticardiolipin Biopsy MRI Aorta


Anti Topoisomerase Anti b2 Glycoprotein 1
Lupus Anticoagulant
Treatment Steroids Anticoagulants & Steroids Steroids
Aspirin

Treatment of PAH lowering drugs TLT


Emergency

You might also like